News

Endometriosis is one of the most common gynecologic diseases, affecting an estimated 5 million women in the United States. The condition occurs when tissue that normally lines the inside of the uterus grows outside the uterus. Pain and infertility are its primary symptoms.

Using sophisticated computer-based technology to analyze genetic data obtained from uterine tissue, researchers have identified patterns of genetic activity that can be used to diagnose endometriosis, an often-painful condition that occurs when tissue that normally lines the inside of the uterus grows outside the uterus. The prototype diagnostic method, developed with funding from the National Institutes of Health, can not only distinguish endometriosis from other disorders of the uterus, but can also identify the severity of the disease.

Lisa M. Halvorson, M.D., has been named the new Chief of the Gynecologic Health and Disease Branch (GHDB), effective June 15, 2014, announced Dr. Catherine Spong, M.D., Director of the Division of Extramural Research.

Endometriosis is a condition in which a type of tissue called the endometrium, which normally lines a woman’s uterus, grows elsewhere in her pelvic cavity. These growths of endometrial tissue are called “implants,” “nodules,” or “lesions” and may be found on a woman’s ovaries, fallopian tubes, bowel, bladder, or other locations.

With 11 research programs, more than 75 researchers, and more than 1,100 support staff, the NICHD's DIR is among the largest at the NIH. But with good reason—The NICHD's DIR also has one of the broadest research portfolios at the NIH, covering nearly all aspects of human development and reproduction.

As National Women’s Health Week (May 12 to 18) gets underway this year, the NICHD takes stock of 15 years of research on diagnosing, preventing, and treating PFDs—a groups of conditions that particularly affect women.

The Division’s 2012 Annual Report highlights the extensive and comprehensive work of DESPR investigators and researchers.

Endometriosis is a disease in which tissue similar to the endometrium, which normally grows inside the uterus, grows outside the uterus instead. Although the exact number of women affected by endometriosis is not known, current estimates suggest that 176 million women worldwide may be affected by the condition.

On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.

​Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.

A document charting a research course for the many collaborators who share an interest in promoting the science concerning human development through the life span, child health, women's health, and rehabilitation research is now available online.

As the Institute marks its golden anniversary, we look back on the NICHD's early years, its scientific accomplishments, and its future.

Although it could affect anywhere from 9% to 18% or more of women age 18 to 64 at any time during their lives, there are few definitive answers about vulvodynia—a group of conditions characterized by unexplained pain of the vulva.

In 2011, the NICHD-led Endometriosis: Natural History, Diagnosis, and Outcomes (ENDO) study found that 11 percent of a group of women with no symptoms of endometriosis actually had the disorder. If this finding is applied to all the women in the United States, the number of American women with endometriosis would well exceed previous estimates of 5 million.

Although the exact number of women with vulvodynia is unknown, researchers estimate that 18 percent of American women from all racial backgrounds experience symptoms of vulvodynia at some point in their lives. The evidence suggests that most women either do not seek help at all, or go from doctor to doctor seeking diagnosis and treatment without answers.

NICHD Director Alan E. Guttmacher, M.D., initiated the NICHD Director’s Lecture Series as a way to showcase cutting-edge science relevant to the Institute’s mission. The forum also enables staff and other attendees to interact with other nationally recognized scientists.

Nearly 24 percent of U.S. women are affected with one or more pelvic floor disorders, report researchers funded by the National Institutes of Health. Their analysis is the first to document in a nationally representative sample the extent of pelvic floor disorders, a cluster of health problems that causes physical discomfort and limits activity.

Vulvodynia is a condition characterized by burning, stinging, irritation, or rawness of the female genital area when there is no apparent infection or skin disease that could cause these symptoms.